Inhaled corticosteroids: benefits and risks.
作者信息
Geddes D M
出版信息
Thorax. 1992 Jun;47(6):404-7. doi: 10.1136/thx.47.6.404.
Abstract
摘要
相似文献
1
Inhaled corticosteroids: benefits and risks.吸入性糖皮质激素：益处与风险。
Thorax. 1992 Jun;47(6):404-7. doi: 10.1136/thx.47.6.404.
2
Inhaled corticosteroids and chronic obstructive pulmonary disease.
J Clin Pharm Ther. 2000 Aug;25(4):235-8. doi: 10.1046/j.1365-2710.2000.00286.x.
3
Early interventions with inhaled corticosteroids in asthma: benefits and risks.哮喘吸入皮质类固醇的早期干预：获益与风险。
Curr Opin Pulm Med. 2011 Jan;17(1):12-5. doi: 10.1097/MCP.0b013e3283410025.
4
Inhaled corticosteroids and the risks of diabetes onset and progression.吸入性皮质类固醇与糖尿病发病和进展的风险。
Am J Med. 2010 Nov;123(11):1001-6. doi: 10.1016/j.amjmed.2010.06.019. Epub 2010 Oct 1.
5
Weighing the benefits and risks of inhaled corticosteroids.权衡吸入性糖皮质激素的利弊。
Curr Opin Pulm Med. 2007 Mar;13(2):89. doi: 10.1097/MCP.0b013e328042bb0c.
6
Inhaled corticosteroids in COPD: quantifying risks and benefits.慢性阻塞性肺疾病中吸入性糖皮质激素：量化风险与益处
Thorax. 2013 Jun;68(6):499-500. doi: 10.1136/thoraxjnl-2012-202959. Epub 2012 Dec 15.
7
Inhaled corticosteroids in COPD: the case against.慢性阻塞性肺疾病中吸入性糖皮质激素：反对的理由
Eur Respir J. 2009 Jul;34(1):13-6. doi: 10.1183/09031936.00190908.
8
The place of high-dose inhaled corticosteroids in asthma therapy.高剂量吸入性糖皮质激素在哮喘治疗中的地位。
Drugs. 1987 May;33(5):423-9. doi: 10.2165/00003495-198733050-00001.
9
[Role of inhaled corticosteroids in the management of COPD].吸入性糖皮质激素在慢性阻塞性肺疾病管理中的作用
Pneumonol Alergol Pol. 2009;77(2):186-91.
10
Inhaled corticosteroids: benefits and risks.吸入性糖皮质激素：益处与风险。
Thorax. 1992 Dec;47(12):1084. doi: 10.1136/thx.47.12.1084-a.
引用本文的文献
1
Inhaled corticosteroids for the treatment of COVID-19.吸入性皮质类固醇治疗 COVID-19。
Cochrane Database Syst Rev. 2022 Mar 9;3(3):CD015125. doi: 10.1002/14651858.CD015125.
2
Oxidative stress and cellular pathways of asthma and inflammation: Therapeutic strategies and pharmacological targets.氧化应激与哮喘和炎症的细胞通路：治疗策略和药理靶点。
Pharmacol Ther. 2018 Jan;181:169-182. doi: 10.1016/j.pharmthera.2017.08.011. Epub 2017 Aug 23.
3
Step 4: stick or twist? A review of asthma therapy.第四步：坚持还是改变？哮喘治疗回顾。
BMJ Open Respir Res. 2016 Sep 5;3(1):e000143. doi: 10.1136/bmjresp-2016-000143. eCollection 2016.
4
Dental treatment in children with asthma - a review.哮喘患儿的牙科治疗——综述
Br Dent J. 2016 Mar 25;220(6):299-302. doi: 10.1038/sj.bdj.2016.220.
5
Prevalence of hypothalamic-pituitary-adrenal axis suppression in children treated for asthma with inhaled corticosteroid.接受吸入性糖皮质激素治疗哮喘的儿童下丘脑-垂体-肾上腺轴抑制的患病率
Paediatr Child Health. 2012 May;17(5):e34-9. doi: 10.1093/pch/17.5.e34.
6
[Therapy of asthma: anti-inflammatory effects of antileukotrienes].
Med Klin (Munich). 1997 Dec;92 Suppl 5:37-40. doi: 10.1007/BF03041978.
7
Glucocorticoid-induced osteoporosis.糖皮质激素性骨质疏松症
Curr Osteoporos Rep. 2009 Mar;7(1):23-6. doi: 10.1007/s11914-009-0005-4.
8
Synthesis and pharmacology of anti-inflammatory steroidal antedrugs.抗炎甾体前药的合成与药理学
Chem Rev. 2008 Dec;108(12):5131-45. doi: 10.1021/cr068203e.
9
Medication-induced osteoporosis.药物性骨质疏松症
Curr Osteoporos Rep. 2007 Dec;5(4):139-45. doi: 10.1007/s11914-007-0008-y.
10
A population based case-control study of cataract and inhaled corticosteroids.一项基于人群的白内障与吸入性皮质类固醇的病例对照研究。
Br J Ophthalmol. 2003 Oct;87(10):1247-51. doi: 10.1136/bjo.87.10.1247.
本文引用的文献
1
Possible association between beclomethasone diproprionate aerosol and cataracts.丙酸倍氯米松气雾剂与白内障之间可能存在的关联。
Aust Paediatr J. 1980 Jun;16(2):117-8. doi: 10.1111/j.1440-1754.1980.tb01276.x.
2
3
Topical and systemic glucocorticoid potencies of budesonide, beclomethasone dipropionate and prednisolone in man.布地奈德、丙酸倍氯米松和泼尼松龙在人体中的局部及全身糖皮质激素效力
Eur J Respir Dis Suppl. 1982;122:74-82.
4
Comparison between inhaled and oral corticosteroids in patients with chronic asthma.慢性哮喘患者吸入性与口服糖皮质激素的比较
Eur J Respir Dis Suppl. 1982;122:154-62.
5
Methodological aspects on clinical trials with inhaled corticosteroids: results of two comparisons between two steroid aerosols in patients with asthma.
Eur J Respir Dis Suppl. 1982;122:108-17.
6
Asthma treatment with a new corticosteroid aerosol, budesonide, administered twice daily by spacer inhaler.使用一种新型皮质类固醇气雾剂布地奈德进行哮喘治疗，通过储雾罐吸入器每日给药两次。
Arch Dis Child. 1982 Nov;57(11):864-6. doi: 10.1136/adc.57.11.864.
7
Glucocorticoids and asthma. Studies of resistance and systemic effects of glucocorticoids.糖皮质激素与哮喘。糖皮质激素抵抗及全身效应的研究。
Eur J Respir Dis Suppl. 1984;136:69-79.
8
Dysphonia caused by inhaled steroids: recognition of a characteristic laryngeal abnormality.吸入性类固醇引起的发声障碍：一种特征性喉部异常的识别。
Thorax. 1984 Sep;39(9):686. doi: 10.1136/thx.39.9.686.
9
10
High-dose beclomethasone inhaler in the treatment of asthma.高剂量倍氯米松吸入器治疗哮喘
Lancet. 1983 Feb 5;1(8319):265-9. doi: 10.1016/s0140-6736(83)91686-0.
Zotero 插件